Reactions Weekly

, Volume 1182, Issue 1, pp 3–3 | Cite as

How serious is heart failure risk with pioglitazone?

Clinical study


Public Health Adverse Event Placebo Heart Failure Placebo Group 


  1. 1.
    Erdmann E, Charbonnel B, Wilcox RG, Skene AM, Massi-Benedetti M, Yates J, Tan M, Spanheimer R, Standl E, Dormandy JA, PROactive investigators.Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive Study (PROactive 08). Diabetes Care 30: 2773-2778, No. 11, Nov 2007Google Scholar

Copyright information

© Adis International limited or Adis Data Information BV 2007

Personalised recommendations